Product
Oslif
1 clinical trial
1 indication
Indication
Chronic Obstructive Pulmonary DiseaseClinical trial
The ANTES B+ Study: An Open-label, Pragmatic, Randomized, Controlled Trial of Triple Therapy Versus LABA-LAMA Combination to Improve Clinical Control in High Risk GOLD B Patients (B+)Status: Recruiting, Estimated PCD: 2025-09-01